PR Hub

Janssen Pharmaceutical

Abiraterone Acetate Significantly Improves Overall Survival of Patients With Post-Chemotherapy Metastatic Castration-Resistant Prostate Cancer


HIGH WYCOMBE, England, May 25, 2011 - - Findings Published Today in The New England Journal of Medicine A study published today in The New England Journal of Medicine in patients with metastatic advanced prostate cancer following chemotherapy who were treated with abiraterone acetate plus prednisone/prednisolone showed a significant improvement in overall survival compared to patients treated with prednisone/prednisolone plus placebo.
MORE..
Older News
S M T W T F S
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
Copyright© 2011 The Gaea Times